Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1998 May;53(5):341–345. doi: 10.1136/thx.53.5.341

Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome

H Engleman 1, S Martin 1, R Kingshott 1, T Mackay 1, I Deary 1, N Douglas 1
PMCID: PMC1745223  PMID: 9708223

Abstract

BACKGROUND—Patients with the sleep apnoea/hypopnoea syndrome (SAHS) report improved sleepiness, cognitive function, and psychological well being after continuous positive airway pressure (CPAP) therapy, and it is for these daytime features that CPAP is usually given. However, few randomised or controlled studies exist on the effects of CPAP on daytime function.
METHODS—A prospective, randomised, single blind, placebo controlled, crossover trial of daytime function after CPAP was conducted in 23 patients with SAHS, all with ⩾15 apnoeas+hypopnoeas/hour and ⩾2 symptoms of SAHS. All patients spent four weeks on CPAP therapy and four weeks on oral placebo treatment, following randomisation to treatment order. With ethics committee approval, patients were told the placebo tablet might improve upper airway function. Average effective CPAP use was monitored using hidden time clocks. Assessments of objective and subjective sleepiness, symptoms, cognitive performance, and psychological well being were performed on the last day of each treatment and compared.
RESULTS—Objective sleepiness measured by sleep onset latency on the multiple sleep latency test improved with CPAP (mean difference from placebo +2.4 min, 95% CI 0.8 to 4.0; p<0.001) as did subjective sleepiness on the Epworth scale (mean difference -6, 95% CI -3 to -9; p = 0.001). Symptom total score also fell with CPAP (mean difference -1.6, 95% CI -2.2 to -1.0; p<0.001). No determinants of these changes with active treatment were identified, and no significant enhancements to cognitive function or psychosocial well being were found in this small sample.
CONCLUSIONS—These findings provide further evidence for clinically significant benefits to daytime function from CPAP.



Full Text

The Full Text of this article is available as a PDF (109.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bédard M. A., Montplaisir J., Malo J., Richer F., Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol. 1993 Mar;15(2):330–341. doi: 10.1080/01688639308402567. [DOI] [PubMed] [Google Scholar]
  2. Cheshire K., Engleman H., Deary I., Shapiro C., Douglas N. J. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med. 1992 Mar;152(3):538–541. [PubMed] [Google Scholar]
  3. Engleman H. M., Asgari-Jirhandeh N., McLeod A. L., Ramsay C. F., Deary I. J., Douglas N. J. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest. 1996 Jun;109(6):1470–1476. doi: 10.1378/chest.109.6.1470. [DOI] [PubMed] [Google Scholar]
  4. Engleman H. M., Martin S. E., Deary I. J., Douglas N. J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997 Feb;52(2):114–119. doi: 10.1136/thx.52.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Engleman H. M., Martin S. E., Deary I. J., Douglas N. J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994 Mar 5;343(8897):572–575. doi: 10.1016/s0140-6736(94)91522-9. [DOI] [PubMed] [Google Scholar]
  6. Gould G. A., Whyte K. F., Rhind G. B., Airlie M. A., Catterall J. R., Shapiro C. M., Douglas N. J. The sleep hypopnea syndrome. Am Rev Respir Dis. 1988 Apr;137(4):895–898. doi: 10.1164/ajrccm/137.4.895. [DOI] [PubMed] [Google Scholar]
  7. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Johns M. W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992 Aug;15(4):376–381. doi: 10.1093/sleep/15.4.376. [DOI] [PubMed] [Google Scholar]
  9. Kribbs N. B., Pack A. I., Kline L. R., Getsy J. E., Schuett J. S., Henry J. N., Maislin G., Dinges D. F. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis. 1993 May;147(5):1162–1168. doi: 10.1164/ajrccm/147.5.1162. [DOI] [PubMed] [Google Scholar]
  10. Krieger J., Weitzenblum E., Monassier J. P., Stoeckel C., Kurtz D. Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea. Lancet. 1983 Dec 17;2(8364):1429–1430. doi: 10.1016/s0140-6736(83)90966-2. [DOI] [PubMed] [Google Scholar]
  11. Mawhinney H., Spector S. L., Kinsman R. A., Siegel S. C., Rachelefsky G. S., Katz R. M., Rohr A. S. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy. 1991 Apr;66(4):294–299. [PubMed] [Google Scholar]
  12. Reeves-Hoche M. K., Meck R., Zwillich C. W. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med. 1994 Jan;149(1):149–154. doi: 10.1164/ajrccm.149.1.8111574. [DOI] [PubMed] [Google Scholar]
  13. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J. 1995 Sep;130(3 Pt 1):572–579. doi: 10.1016/0002-8703(95)90368-2. [DOI] [PubMed] [Google Scholar]
  14. Smith IE, Shneerson JM. Is the SF 36 sensitive to sleep disruption? A study in subjects with sleep apnoea. J Sleep Res. 1995 Sep;4(3):183–188. doi: 10.1111/j.1365-2869.1995.tb00167.x. [DOI] [PubMed] [Google Scholar]
  15. Thorpy M. J. The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association. Sleep. 1992 Jun;15(3):268–276. doi: 10.1093/sleep/15.3.268. [DOI] [PubMed] [Google Scholar]
  16. Whyte K. F., Allen M. B., Jeffrey A. A., Gould G. A., Douglas N. J. Clinical features of the sleep apnoea/hypopnoea syndrome. Q J Med. 1989 Jul;72(267):659–666. [PubMed] [Google Scholar]
  17. Wright J., Johns R., Watt I., Melville A., Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ. 1997 Mar 22;314(7084):851–860. doi: 10.1136/bmj.314.7084.851. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES